Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.

Juracek J, Slaby O.

Methods Mol Biol. 2020;2115:221-247. doi: 10.1007/978-1-0716-0290-4_13.

PMID:
32006404
2.

Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.

Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M.

Cancers (Basel). 2019 Oct 17;11(10). pii: E1580. doi: 10.3390/cancers11101580. Review.

3.

MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients.

Kovacova J, Juracek J, Poprach A, Kopecky J, Fiala O, Svoboda M, Fabian P, Radova L, Brabec P, Buchler T, Slaby O.

Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):353-359. doi: 10.21873/cgp.20140.

4.

Identification of microRNA signatures in umbilical cord blood associated with maternal characteristics.

Juracek J, Piler P, Janku P, Radova L, Slaby O.

PeerJ. 2019 May 30;7:e6981. doi: 10.7717/peerj.6981. eCollection 2019.

5.

Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database.

Poprach A, Rumanova K, Lakomý R, Chloupková R, Stanik M, Pokrivcak T, Kiss I, Slaby O, Studentova H, Melichar B, Juracek J, Fiala O, Kopecky J, Kopeckova K, Zemanova M, Buchler T.

Urol Oncol. 2019 Apr;37(4):294.e1-294.e8. doi: 10.1016/j.urolonc.2018.12.017. Epub 2019 Jan 23.

PMID:
30683455
6.

MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study.

Kopkova A, Sana J, Fadrus P, Machackova T, Vecera M, Vybihal V, Juracek J, Vychytilova-Faltejskova P, Smrcka M, Slaby O.

PLoS One. 2018 Dec 7;13(12):e0208580. doi: 10.1371/journal.pone.0208580. eCollection 2018.

7.

Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.

Juracek J, Stanik M, Vesela P, Radova L, Dolezel J, Svoboda M, Slaby O.

Urol Oncol. 2019 Mar;37(3):184.e1-184.e7. doi: 10.1016/j.urolonc.2018.10.014. Epub 2018 Nov 13.

PMID:
30446443
8.

Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response.

Kovacova J, Juracek J, Poprach A, Buchler T, Kopecky J, Fiala O, Svoboda M, Slaby O.

Anticancer Res. 2018 May;38(5):2961-2965.

PMID:
29715124
9.

Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.

Juracek J, Peltanova B, Dolezel J, Fedorko M, Pacik D, Radova L, Vesela P, Svoboda M, Slaby O, Stanik M.

J Cell Mol Med. 2018 Mar;22(3):2033-2038. doi: 10.1111/jcmm.13487. Epub 2018 Jan 24.

10.

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry.

Lakomy R, Poprach A, Bortlicek Z, Melichar B, Chloupkova R, Vyzula R, Zemanova M, Kopeckova K, Svoboda M, Slaby O, Kiss I, Studentova H, Juracek J, Fiala O, Kopecky J, Finek J, Dusek L, Hejduk K, Buchler T.

BMC Cancer. 2017 Dec 21;17(1):880. doi: 10.1186/s12885-017-3901-5.

11.

Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.

Fedorko M, Juracek J, Stanik M, Svoboda M, Poprach A, Buchler T, Pacik D, Dolezel J, Slaby O.

Biochem Med (Zagreb). 2017 Jun 15;27(2):411-417. doi: 10.11613/BM.2017.043.

12.

Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.

Iliev R, Kleinova R, Juracek J, Dolezel J, Ozanova Z, Fedorko M, Pacik D, Svoboda M, Stanik M, Slaby O.

Tumour Biol. 2016 Oct;37(10):13385-13390. Epub 2016 Jul 27.

PMID:
27460088
13.

MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.

Fedorko M, Pacik D, Wasserbauer R, Juracek J, Varga G, Ghazal M, Nussir MI.

Int J Biol Markers. 2016 Feb 28;31(1):e26-37. doi: 10.5301/jbm.5000174.

PMID:
26481440
14.

Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.

Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P, Svoboda M, Hajduch M, Ehrmann J.

Carcinogenesis. 2015 May;36(5):521-7. doi: 10.1093/carcin/bgv023. Epub 2015 Mar 16.

PMID:
25784377

Supplemental Content

Loading ...
Support Center